Chad Davis is a partner in Goodwin's Technology Companies + Life Sciences Group and a member of its Intellectual Property and Life Sciences Practices. Dr. Davis counsels companies, investors and leading academic institutions on intellectual property matters, especially patent matters. He has extensive experience in prosecution and strategic development of patent portfolios to procure patent protection in the United States and abroad, intellectual property due diligence, and risk assessment through, for example, patent validity and infringement analyses.

With his extensive background in chemistry, Dr. Davis has represented clients in a diverse range of technologies, such as pharmaceuticals, drug delivery technologies, crystal forms, organic dyes, chemical processes, polymers, proteins, stem cell technology, medical diagnostics, medical imaging, microfluidic devices, adhesives, analytical chemistry, foams, cosmetics and optical technologies.





Dr. Davis has significant experience developing and implementing patent portfolio strategies to procure patent protection in the United States and abroad, performing intellectual property due diligence investigations on behalf of investors, financial institutions, and companies in advance of investments in privately held companies, public offerings of securities, strategic alliances, and mergers and acquisitions, and counseling clients on intellectual property risk assessment, post-grant patent proceedings and disputes concerning ownership, validity and infringement of intellectual property rights. For companies developing pharmaceuticals, Dr. Davis develops and implements strategies to maximize patent and regulatory exclusivities for their products.

Exemplary recent representations include:

  • Lycera Corporation, a biopharmaceutical company developing medicines for treating autoimmune disease, to develop and implement patent portfolio strategies to procure patent protection for new chemical compounds and therapeutic methods
  • Esperion Therapeutics, Inc., a biopharmaceutical company developing medicines for treating cardiovascular disease, to develop and patent portfolio strategies to procure patent protection for new chemical compounds and therapeutic methods
  • Diagnostics For All, Inc., a diagnostics company developing medical assay devices, to develop and implement patent portfolio strategies to procure patent protection for new devices for performing medical assays
  • BioAmber, a Montreal-based industrial biotechnology company that produces renewable chemicals, in its IPO on the New York Stock Exchange and the NYSE Euronext
Professional Activities

Dr. Davis is a member of the American Chemical Society, American Intellectual Property Law Association and Intellectual Property Owners Association.

Professional Experience

Prior to joining Goodwin, Dr. Davis was a patent agent at Foley Hoag LLP.


Dr. Davis has been named a 2014 Boston “Rising Star” by the National Law Journal. The list recognizes 40 outstanding lawyers in the Boston area, age 40 or younger.

In The News









J.D., 2007
Boston College Law School
Ph.D., Chemistry, 2003
University of Illinois at Urbana-Champaign
B.S., Chemistry/Geology, 1998
Ball State University

(summa cum laude)



U.S. Patent and Trademark Office (USPTO)
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.


Search Other Lawyers
Recherche par Pratique